Ck-mb assay
| Product | Method | Size | Catalog | Price | Quantity |
| Ck-mb assay | Immunoinhibition | R1 6 x 21ml, R2 2 x 15ml | CK9717 | £401.00 | |
| Shipping costs will be added at the checkout stage, click here for charges. | |||||
- Format
Lyophilised - Assay Range
9.1 - 1230 U/L - Working Stability 15-25 °C
_ - Working Stability 2-8 °C
21 days - Material Safety Data Sheets
Intended Use
For the quantitative in vitro determination of CKMB in serum and plasma. This product is suitable for use on the Hitachi 917 and the Hitachi Modular P.
Clinical Significance
Creatine Kinase (CK) is internationally accepted as a sensitive and specific indicator of acute myocardial infarction (AMI). There are 3 iso-enzymes of CK, CK-MM, CK-MB and CK-BB. CK-BB is produced by the brain in very small insignificant amounts. CK-MM is produced by the skeletal and heart tissue and CK-MB is produced by the heart muscle.
In the vast majority of cases CK activity rises within 6 hours of an acute infarction. After about 20 hours maximum CK values are observed. The CK activity generally returns to normal between the fourth and fifth day post- infarction.
Determination of CK activity in both plasma and serum can therefore provide a sensitive and specific marker for myocardial infarction, hyperthyroidism, kidney disease, cerebrovascular accidents and skeletal muscle diseases such as muscular dystrophy.
Elevated levels of CK are usually associated with damage to the heart or other muscles. It may also indicate excessive exercise or heavy use of the muscles.
Principle
Immunoinhibition Assay: An antibody is incorporated into the CK reagent. This antibody will bind to and inhibit the activity of the M subunit of CK-MB. This means that only the activity of the B subunit in serum is measured. If the activity is multiplied by a factor of 2, it will give the activity of CK-MB in serum.
- Hitachi 917
Related Products
We accept all major credit cards
You can also buy via phone or email
+44 (0) 9442 2413
marketing@randox.com
